Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. [PDF]
J Comp Eff ResStewart EA +6 more
europepmc +1 more source
Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids. [PDF]
Int J Environ Res Public Health, 2020 Szydłowska I +4 more
europepmc +1 more source
Comparative effectiveness and safety of different progestins in combined oral contraceptives: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Arch Gynecol ObstetLi B, Xu X, Xu K, Ni J, Wang C, Zhang T.
europepmc +1 more source
Medical Therapy for Fibroids: What Next for Ulipristal Acetate? [PDF]
Adv Ther, 2021 Ekanem E, Talaulikar V.
europepmc +1 more source
Effects of female hormone withdrawal and ulipristal acetate on MED12 mutation positive and negative uterine leiomyomas using a xenograft model. [PDF]
Sci RepSato S +8 more
europepmc +1 more source
Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial. [PDF]
BMJ Sex Reprod HealthEdelman A +9 more
europepmc +1 more source
Non-surgical intervention for retroperitoneal lymphogenic and pulmonary metastases of a benign leiomyoma: treatment with ulipristal acetate. [PDF]
BMJ Case Rep, 2018 Kortekaas KE, Pelikan HMP.
europepmc +1 more source
The effectiveness of quick starting oral contraception containing nomegestrol acetate and 17-β estradiol on ovulation inhibition: A randomized controlled trial. [PDF]
Sci Rep, 2020 Jirakittidul P +5 more
europepmc +1 more source
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel. [PDF]
ContraceptionEdelman A +9 more
europepmc +1 more source